Vivos Inc (RDGL) stock

RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30

$0.05−0.00 (-2.51%)

Close on Oct 19, 2026Market cap $23.61MP/E –Yield –

Vivos price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Vivos's price to sales ratio was 238.2× on Oct 19, 2026, against 437.0× a year earlier. Over the last 5 years it ranged from 1.4× to 488.7×, with a median of 231.9×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	238.2×	−218.7
2022	Sep 30, 2022	456.9×	+254.4
2018	Apr 30, 2018	202.6×	−174.5
2017	Oct 31, 2017	377.1×	+231.9
2016	Dec 30, 2016	145.1×	−235.9
2015	Dec 31, 2015	381.0×	+368.1
2014	Dec 31, 2014	12.9×	−20.2
2013	Dec 31, 2013	33.1×	−25.8
2012	Dec 31, 2012	59.0×	+42.1
2011	Dec 30, 2011	16.8×	–